Replimune Group, Inc.: Form 10-Q for the period ended Jun 30, 2020
Filed with the SEC on Aug 7, 2020 and accepted by EDGAR at Aug 7, 2020, 08:04 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2020-04-01 to 2020-06-30 | $12.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2020-04-01 to 2020-06-30 | −$17.8m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2020-04-01 to 2020-06-30 | −$17.5m | us-gaap:NetIncomeLoss |
| Operating cash flow | 3 months2020-04-01 to 2020-06-30 | −$15.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2020-04-01 to 2020-06-30 | $932.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2020-06-30 | $104.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-06-30 | $267.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-06-30 | $329.6m | us-gaap:Assets |
| Current liabilities | At period end2020-06-30 | $11.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-06-30 | $51.8m | us-gaap:Liabilities |
| Long-term debt | At period end2020-06-30 | $9.8m | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2020-06-30 | $277.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-20-091744. Last ingested by Listed: Nov 11, 2026, 01:43 ET. Listed shows no prices and gives no investment advice.